C138H175F7N18O12 — CID 158632681
2-[[4-[(2,6-difluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(4-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]quinoxaline;2-[[4-[2-(2-fluorophenyl)-1-methoxyethyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-3-yl]ethanone;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]quinoxalin-2-yl]methyl]piperidin-4-yl]ethanone (PubChem CID 158632681) has the molecular formula C138H175F7N18O12 and a molecular weight of 2411.02 g/mol. Its IUPAC name is 2-[[4-[(2,6-difluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(4-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]quinoxaline;2-[[4-[2-(2-fluorophenyl)-1-methoxyethyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-3-yl]ethanone;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]quinoxalin-2-yl]methyl]piperidin-4-yl]ethanone.
| Compound Name | 2-[[4-[(2,6-difluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(4-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]quinoxaline;2-[[4-[2-(2-fluorophenyl)-1-methoxyethyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-3-yl]ethanone;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]quinoxalin-2-yl]methyl]piperidin-4-yl]ethanone |
|---|---|
| PubChem CID | 158632681 |
| Molecular Formula | C138H175F7N18O12 |
| Molecular Weight | 2411.02 g/mol |
| Exact Mass | 2409.35 |
| IUPAC Name | 2-[[4-[(2,6-difluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(4-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]quinoxaline;2-[[4-[2-(2-fluorophenyl)-1-methoxyethyl]piperidin-1-yl]methyl]-3-[(2-methylpropan-2-yl)oxy]pyrazine;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-3-yl]ethanone;2-(2-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]quinoxalin-2-yl]methyl]piperidin-4-yl]ethanone |
| SMILES | CC(C)(C)Oc1nc2ccccc2nc1CN1CCC(C(=O)Cc2ccccc2F)CC1.CC(C)(C)Oc1nc2ccccc2nc1CN1CCC(COc2ccccc2F)CC1.CC(C)(C)Oc1nccnc1CN1CCC(COc2c(F)cccc2F)CC1.CC(C)(C)Oc1nccnc1CN1CCC(COc2ccc(F)cc2)CC1.CC(C)(C)Oc1nccnc1CN1CCCC(C(=O)Cc2ccccc2F)C1.COC(Cc1ccccc1F)C1CCN(Cc2nccnc2OC(C)(C)C)CC1 |
| InChI | InChI=1S/C26H30FN3O2.C25H30FN3O2.C23H32FN3O2.C22H28FN3O2.C21H27F2N3O2.C21H28FN3O2/c1-26(2,3)32-25-23(28-21-10-6-7-11-22(21)29-25)17-30-14-12-18(13-15-30)24(31)16-19-8-4-5-9-20(19)27;1-25(2,3)31-24-22(27-20-9-5-6-10-21(20)28-24)16-29-14-12-18(13-15-29)17-30-23-11-7-4-8-19(23)26;1-23(2,3)29-22-20(25-11-12-26-22)16-27-13-9-17(10-14-27)21(28-4)15-18-7-5-6-8-19(18)24;1-22(2,3)28-21-19(24-10-11-25-21)15-26-12-6-8-17(14-26)20(27)13-16-7-4-5-9-18(16)23;1-21(2,3)28-20-18(24-9-10-25-20)13-26-11-7-15(8-12-26)14-27-19-16(22)5-4-6-17(19)23;1-21(2,3)27-20-19(23-10-11-24-20)14-25-12-8-16(9-13-25)15-26-18-6-4-17(22)5-7-18/h4-11,18H,12-17H2,1-3H3;4-11,18H,12-17H2,1-3H3;5-8,11-12,17,21H,9-10,13-16H2,1-4H3;4-5,7,9-11,17H,6,8,12-15H2,1-3H3;4-6,9-10,15H,7-8,11-14H2,1-3H3;4-7,10-11,16H,8-9,12-15H2,1-3H3 |
| InChIKey | HZJSCOVUXPLUBV-UHFFFAOYSA-N |
| XLogP | 26.59 |
| TPSA | 300.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 175 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2411.02 |
| LogP ≤ 5 | 26.59 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |